Department of Health and Human Services February 2005 – Federal Register Recent Federal Regulation Documents

Results 101 - 150 of 326
Agency Information Collection Activities Under Emergency Review by the Office of Management and Budget
Document Number: 05-3136
Type: Notice
Date: 2005-02-18
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 05-3127
Type: Notice
Date: 2005-02-18
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
Blood Pressure Measurement Devices (Sphygmomanometers)-Accuracy; Draft Revised Compliance Policy Guide; Availability
Document Number: 05-3116
Type: Notice
Date: 2005-02-18
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft revised guidance for FDA staff and industry entitled ``Compliance Policy Guide (CPG) Sec. 310.210 Blood Pressure Measurement Devices (Sphygmomanometers)Accuracy (CPG 7124.23).'' This draft CPG provides guidance concerning accuracy and exhaust rate criteria for sphygmomanometers. This draft guidance is being issued for public comment only and will not be implemented until a final CPG is announced in the Federal Register.
Nonprescription Drugs Advisory Committee; Notice of Meeting
Document Number: 05-3115
Type: Notice
Date: 2005-02-18
Agency: Food and Drug Administration, Department of Health and Human Services
Implantation or Injectable Dosage Form New Animal Drugs; Trenbolone and Estradiol
Document Number: 05-3107
Type: Rule
Date: 2005-02-18
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Ivy Laboratories, Division of Ivy Animal Health, Inc. The supplemental ANADA provides for an additional dose of trenbolone acetate and estradiol implant for use in feedlot heifers for increased rate of weight gain and improved feed efficiency.
Draft Guidance for Industry: Considerations for Plasmid Deoxyribonucleic Acid Vaccines for Infectious Disease Indications; Availability
Document Number: 05-3106
Type: Notice
Date: 2005-02-18
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled ``Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications'' dated February 2005. The draft guidance document is intended to assist manufacturers and/or sponsors in the development and testing of deoxyribonucleic acid (DNA) vaccines to prevent infectious diseases. The draft guidance, when finalized, will update and replace the guidance document entitled ``Points to Consider on Plasmid DNA Vaccines for Preventive Infectious Disease Indications'' dated December 1996.
Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB)
Document Number: 05-3044
Type: Notice
Date: 2005-02-18
Agency: Department of Health and Human Services, Centers for Medicare and Medicaid Services, Centers for Medicare & Medicaid Services
Office of Child Support Enforcement; Special Improvement Project (SIP) Grants
Document Number: 05-3090
Type: Notice
Date: 2005-02-17
Agency: Administration for Children and Families, Department of Health & Human Services, Children and Families Administration, Department of Health and Human Services
The Administration for Children and Families (ACF), Office of Child Support Enforcement (OCSE) invites eligible applicants to submit competitive grant applications for special improvement projects, which further the national child support mission, vision, and goals. For FY 2005, OCSE is looking for projects that reflect the goals of the new FY 2005-2009 strategic plan including the goals that all children have parentage established; and all children in IV-D (child support) cases have support orders established, have medical coverage and receive financial support from parents as ordered. The last goal of the strategic plan is that the IV-D program will be efficient and responsive in its operations. Applications will be screened and evaluated as indicated in this program announcement. Awards will be contingent upon the outcome of the competition and the availability of funds. For FY 2005, approximately $1.8 million is available for all priority areas. A non-Federal match is not required. The anticipated start date for the new awards is August 1, 2005; projects under Priority 1 may run through December 31, 2006, for a period of up to 17 months; projects under Priorities 2, 4 and 5 may run through July 31, 2007, for a period of up to 24 months and projects under Priority 3 may run through July 31, 2008, for a period of up to 36 months. Legislative Authority: Section 452(j) of the Social Security Act, 42 U.S.C. 652(j), provides Federal funds for information dissemination and technical assistance to States, training of Federal and State staff to improve child support programs, and research, demonstration, and special projects of regional or national significance relating to the operation of State child support enforcement programs.
State Median Income Estimate for a Four-Person Family (FFY 2006); Notice of the Federal Fiscal Year (FFY) 2006 State Median Income Estimates for Use Under the Low Income Home Energy Assistance Program (LIHEAP) Administration by the Administration for Children and Families, Office of Community Services, Division of Energy Assistance
Document Number: 05-3088
Type: Notice
Date: 2005-02-17
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
This notice announces the estimated median income for four- person families in each State and the District of Columbia for FFY 2006 (October 1, 2005 to September 30, 2006). LIHEAP grantees may adopt the State median income estimates beginning with the date of this publication of the estimates in the Federal Register or at a later date as discussed below. This means that LIHEAP grantees could choose to implement this notice during the period between the heating and cooling seasons. However, by October 1, 2005, or by the beginning of a grantee's fiscal year, whichever is later, LIHEAP grantees using State median income estimates must adjust their income eligibility criteria to be in accord with the FFY 2006 State median income estimates. This listing of estimate State median incomes provides one of the maximum income criteria that LIHEAP grantees may use in determining a household's income eligibility for LIHEAP.
Agency Recordkeeping/Reporting Requirements Under Emergency Review by the Office of Management and Budget (OMB)
Document Number: 05-3087
Type: Notice
Date: 2005-02-17
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Announcement of Anticipated Availability of Funds for Family Planning Services Grants
Document Number: 05-3059
Type: Notice
Date: 2005-02-17
Agency: Department of Health and Human Services
The Office of Population Affairs, Office of Public Health and Science, Department of Health and Human Services, published a notice in the Federal Register July 7, 2004, announcing the anticipated availability of funds for family planning services grants. This notice contained an error. An eligible Population/area was not listed as available for competition in 2005. A document correcting the omission of the Seattle, Washington Population/area as competitive in 2005 was published in the Federal Register August 10, 2004. Later, two additional Populations/areas, Illinois, Chicago area and Arizona, Navajo Nation, became available for competition in 2005. A second correction notice was published in the Federal Register November 22, 2004, which included all Populations/areas available for competition in 2005. Since that time, it has been recognized that the project period start date indicated in Table I for the Seattle, Washington Population/ area is incorrect. This notice corrects the project period start date to 09/30/2005 for the FY 2005 competitive year. However, the first year of the project period beginning 09/30/2005 will be abbreviated. The budget period for the 01-year will end on 06/30/2006. In subsequent years, the annualized budget period will begin on 07/01 of each project period year, and will end on 06/30 of each project period year. The purpose of this change is to modify the project period start and end dates for the Seattle, Washington Population/area in order to enhance project oversight.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 05-3054
Type: Notice
Date: 2005-02-17
Agency: Department of Health and Human Services, Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 05-3042
Type: Notice
Date: 2005-02-17
Agency: Office of the Secretary, Department of Health and Human Services
Food Additives Permitted for Direct Addition to Food for Human Consumption; Acacia (Gum Arabic)
Document Number: 05-3026
Type: Rule
Date: 2005-02-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of acacia (gum arabic) as a thickener, emulsifier, or stabilizer in alcoholic beverages at a maximum use level of 20 percent. This action is in response to a petition filed by Kerry, Inc.
Kerry, Inc.; Withdrawal of Generally Recognized as Safe Affirmation Petition
Document Number: 05-3024
Type: Notice
Date: 2005-02-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the withdrawal, without prejudice to a future filing, of a generally recognized as safe (GRAS) affirmation petition (GRASP 3G0287) proposing that the use of gum acacia (arabic) in alcoholic beverages up to a maximum level of 20 percent in the finished preparation (liqueur) is GRAS.
Agency Information Collection Activities: Proposed Collection: Comment Request
Document Number: 05-3023
Type: Notice
Date: 2005-02-17
Agency: Department of Health and Human Services, Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection: Comment Request
Document Number: 05-3022
Type: Notice
Date: 2005-02-17
Agency: Department of Health and Human Services, Health Resources and Services Administration
Scientific Considerations Related to Developing Follow-On Protein Products; Reopening of Comment Period
Document Number: 05-3027
Type: Notice
Date: 2005-02-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is reopening until March 16, 2005, the comment period for the notice that appeared in the Federal Register of August 16, 2004 (69 FR 50386). In the notice, FDA announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products and plans to develop draft guidance and requested comments related to developing and approving follow-on protein pharmaceutical products. The agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.
Health Professions Preparatory, Health Professions Pregraduate and Indian Health Professions Scholarship Programs: Correction
Document Number: 05-2971
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, Indian Health Service
The Indian Health Service published a document in the Federal Register on January 19, 2005. The document contained two errors.
Advisory Committee to the Director, Centers for Disease Control and Prevention
Document Number: 05-2961
Type: Notice
Date: 2005-02-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Center For Scientific Review; Notice of Closed Meetings
Document Number: 05-2960
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: 05-2959
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Document Number: 05-2958
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-2957
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Document Number: 05-2956
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Document Number: 05-2955
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Amended Notice of Meeting
Document Number: 05-2954
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting
Document Number: 05-2953
Type: Notice
Date: 2005-02-16
Agency: Department of Health and Human Services, National Institutes of Health
Industry Exchange Workshop on Food and Drug Administration Clinical Trial Requirements; Public Workshop
Document Number: 05-2922
Type: Notice
Date: 2005-02-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) Philadelphia District, in cooperation with the Society of Clinical Research Associates (SoCRA), is announcing a workshop on FDA Clinical trial statutory and regulatory requirements. This 2-day workshop for the clinical research community targets sponsors, monitors, clinical investigators, institutional review boards, and those who interact with them for the purpose of conducting FDA regulated clinical research. The workshop will include both industry and FDA perspectives on proper conduct of clinical trials regulated by FDA. Date and Time: The public workshop is scheduled for Wednesday, April 13, 2005, from 8:15 a.m. to 5 p.m. and Thursday, April 14, 2005, from 8:15 a.m. to 4 p.m. Location: The public workshop will be held at the Sheraton University City Hotel Philadelphia, 3549 Chestnut St., Philadelphia, PA 19104, 215-387-8000, FAX: 215-387-7920. Contact: Marie Falcone, Food and Drug Administration, U.S. Customhouse, 200 Chestnut St., rm. 900, Philadelphia, PA 19106, 215- 597-2120 ext. 4003, FAX: 215-597-5798, e-mail: mfalcone@ora.fda.gov. Registration: Send registration information (including name, title, firm name, address, telephone, and fax number) and the registration fee of $485 (member), $560 (nonmember), or $460 (government employee nonmember). (Registration fee for nonmemebers includes a 1 year membership.) The registration fee for FDA employees is waived. Make the registration fee payable to SoCRA, P.O. Box 101, Furlong, PA 18925. To register via the Internet go to https://www.socra.org/FDA Conference.htm. (FDA has verified the Web site address, but is not responsible for subsequent changes to the Web site after this document publishes in the Federal Register.) The registrar will also accept payment by major credit cards. For more information on the meeting, or for questions on registration, contact 800-SoCRA92 (800-762-7292), or 215-345-7369, or via e-mail: socramail@aol.com. Attendees are responsible for their own accommodations. To make reservations at the Sheraton University City Hotel at the reduced conference rate, contact the Sheraton University City Hotel (see Location) before March 13, 2005. The registration fee will be used to offset the expenses of hosting the conference, including meals, refreshments, meeting rooms, and materials. Space is limited, therefore interested parties are encouraged to register early. Limited onsite registration may be available. Please arrive early to ensure prompt registration. If you need special accommodations due to a disability, please contact Marie Falcone (see Contact) at least 7 days in advance of the workshop.
Food and Drug Administration Drug Educational Forum; Public Workshop; Correction
Document Number: 05-2921
Type: Notice
Date: 2005-02-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of February 3, 2005 (70 FR 5686). The document announced a public workshop. The document was published with a typographical error in the Supplementary Information section. This document corrects that error.
Advisory Commission on Childhood Vaccines; Notice of Meeting
Document Number: 05-2881
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, Health Resources and Services Administration
Announcement of the CDC-Wide Research Agenda Development Public Participation Meetings
Document Number: 05-2852
Type: Notice
Date: 2005-02-15
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry (CDC) is developing a CDC-Wide Research Agenda, and invites the public to provide input. Four Research Agenda Development Public Participation Meetings will be held across the country (March 8, 2005, Arlington, VA; March 18, 2005, Atlanta, GA; March 24, 2005, Seattle, WA; and March 31, 2005, Columbus, OH). Background: On January 10, 2005, the Centers for Disease Control and Prevention launched an effort to develop its first ever, agency- wide public health research agenda. The new agenda will address and support CDC's health protection goals (https://www.cdc.gov/futures/ Goals01-6-05.pdf). The agenda will also provide overall guidance for CDC's intramural and extramural research as well as serve as an effective planning and communication tool for CDC's public health research. Request for Comments: The public is invited to participate in the development of the CDC-Wide Research Agenda. The CDC will host four Research Agenda Development Public Participation Meetings. These events will give researchers, representatives of CDC key partner organizations and the public the opportunity to voice their opinions regarding the future direction of CDC's public health research. The four meetings will be held: March 8, 2005, 8:30 a.m.-5 p.m., Hilton Crystal City Hotel at Ronald Reagan National Airport, 2399 Jefferson Davis Highway, Arlington, VA 22202; telephone 703-418-6800. Registration begins February 25, 2005. March 18, 2005, 8:30 a.m.-5 p.m., National Center for Primary Care at Morehouse School of Medicine, 720 Westview Dr., SW., Atlanta, GA 30310; telephone 404-756-5740. Registration begins March 4, 2005. March 24, 2005, 8:30 a.m.-5 p.m., Crowne Plaza Seattle, 1113 Sixth Avenue, Seattle, WA 98101; telephone 206-464-1980. Registration begins March 11, 2005. March 31, 2005, 8:30 a.m.-5 p.m., Hyatt Regency, 350 North High Street, Columbus, OH, 43215; telephone 614-463-1234. Registration begins March 18, 2005. Attendance by the public will be limited to the space available. Please communicate with the individuals listed below to request special accommodations for persons with disabilities. All those wishing to attend any of the meetings must register. See specific meeting above for date of registration. To register, please visit https://www.maximumtechnology.com/cdcreg.htm. Additional information will be available as of February 21st via the Office of Public Health Research Web site, https://www.cdc.gov/od/ophr/, or may be obtained by communicating with the contact whose name and telephone number is listed below. Contacts: Ms. Mollie Ergle, Meeting Coordinator, Office of Public Health Research, Centers for Disease Control and Prevention, Mail Stop E-72 1600 Clifton Rd. NE., Atlanta, GA 30333, E-mail: mergle@cdc.gov. Phone: 404-498-0132; Fax: 404-498-0011. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and ATSDR.
Agency for Toxic Substances and Disease Registry Academic Partners Public Health Training Grant
Document Number: 05-2851
Type: Notice
Date: 2005-02-15
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services, Agency for Toxic Substances and Disease Registry
National Committee on Vital and Health Statistics: Meeting
Document Number: 05-2849
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services
Submission for OMB Review; Comment Request; Hazardous Waste Worker Training
Document Number: 05-2830
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, National Institutes of Health/national Institute of Environmental Health Sciences; Division of Extramural Research and Training, National Institutes of Health
Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institute of Environmental Health Sciences (NIEHS), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on December 8, 2004, pages 71061-71062, and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Proposed Collection: Title: Hazardous Waste Worker Training42 CFR Part 65. Type of Information Collection Request: Revision of OMB No. 0925-0348, expiration date February 28, 2005. Need and Use of Information Collection: This request for OMB review and approval of the information collection is required by regulation 42 CFR part 65(a)(6). The National Institute of Environmental Health Sciences (NIEHS) has been given major responsibility for initiating a worker safety and health training program under Section 126 of the Superfund Amendments and Reauthorization Act of 1986 (SARA) for hazardous waste workers and emergency responders. A network of non-profit organizations that are committed to protecting working and their communities by delivering high-quality, peer-reviewed safety and health curricula to target populations of hazardous waste workers and emergency responders has been developed. In seventeen years (FY 1987-2004), the NIEHS Worker Training program has successfully supported 20 primary grantees that have trained more than 1.3 million workers across the country and presented over 69,000 classroom and hands-on training courses, which have accounted for nearly 18 million contact hours of actual training. Generally, the grant will initially be for one year, and subsequent continuation awards are also for one year at a time. Grantees must submit a separate application to have the support continued for each subsequent year. Grantees are to provide information in accordance with S65.4 (a), (b), (c) and 65.6 (b) on the nature, duration, and purpose of the training, selection criteria for trainees' qualifications and competency of the project director and staff, cooperative agreements in the case of joint applications, the adequacy of training plans and resources, including budget and curriculum, and response to meeting training criteria in OSHA's Hazardous Waste Operations and Emergency Response Regulations (29 CFR 1910.120). As a cooperative agreement, there are additional requirements for the progress report section of the application. Grantees are to provide their information in hard copy as well as enter information into the WETP Grantee Data Management System. The information collected is used by the Director through officers, employees, experts, and consultants to evaluate applications based on technical merit to determine whether to make awards. Frequency of Response: Biannual. Affected Public: Non-profit organizations. Type of Respondents: Grantees. The annual reporting burden is as follows: Estimated Number of Respondents: 18; Estimated Number of Responses per Respondent: 2; Average Burden Hours Per Response: 10; and Estimated Total Annual Burden Hours Requested: 360. The annualized cost to respondents is estimated at: $10,764. There are no Capital Costs, Operating Costs and/or Maintenance Costs to report. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Joseph T. Hughes, Jr., Director, Worker Education and Training Program, Division of Extramural Research and Training, NIEHS, P.O. Box 12233, Research Triangle Park, NC 27709 or call non-toll-free number (919) 541-0217 or E-mail your request, including your address to wetp@niehs.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
State-of-the-Science Conference on Management of Menopausal Symptoms; Notice
Document Number: 05-2829
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Information Collection Activity; Comment Request Proposed Projects:
Document Number: 05-2826
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Submission for OMB Review; Comment Request
Document Number: 05-2825
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Draft Guidance on the Open Public Hearing; Food and Drug Administration Advisory Committee Meetings; Availability
Document Number: 05-2822
Type: Notice
Date: 2005-02-15
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance document entitled ``The Open Public Hearing; FDA Advisory Committee Meetings.'' This draft guidance is for members of the public who choose to participate in the open public hearing (OPH) session of an FDA advisory committee meeting. The draft guidance is intended to answer more fully questions about how the public may participate at an OPH session, and it includes topics such as meeting logistics and administrative requirements.
Draft Guidance for Industry on Internal Radioactive Contamination-Development of Decorporation Agents; Availability
Document Number: 05-2821
Type: Notice
Date: 2005-02-15
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Internal Radioactive ContaminationDevelopment of Decorporation Agents.'' This draft document provides guidance to industry on the development of decorporation agents for the treatment of internal radioactive contamination when evidence is needed to demonstrate the effectiveness of the agents, but human efficacy studies are unethical or infeasible. In such instances, the Animal Efficacy Rule may be invoked to approve new medical products not previously marketed or new indications for previously marketed products. Specifically, this draft guidance addresses chemistry, manufacturing and controls (CMC) information; animal efficacy, safety pharmacology, and toxicology studies; clinical pharmacology, biopharmaceutics, and human safety studies; and postapproval commitments.
Agency Information Collection Activities: Proposed Collection: Comment Request
Document Number: 05-2820
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection: Comment Request
Document Number: 05-2819
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, Health Resources and Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 05-2818
Type: Notice
Date: 2005-02-15
Agency: Department of Health and Human Services, Health Resources and Services Administration
Secondary Direct Food Additives Permitted in Food for Human Consumption
Document Number: 05-2808
Type: Rule
Date: 2005-02-14
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the food additive regulations to permit the manufacture of chlorine dioxide by electrolysis of an aqueous solution of sodium chlorite. This action is in response to a petition filed by Vulcan Chemicals.
Proposed Collection; Comment Request; The Agricultural Health Study: A Prospective Cohort Study of Cancer and Other Diseases Among Men and Women in Agriculture
Document Number: 05-2773
Type: Notice
Date: 2005-02-14
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of Section 3506(c0(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Proposed Collection: Title: The Agricultural Health StudyA Prospective Cohort Study of Cancer and Other Diseases Among Men and Women in Agriculture: Phase III. Type of Information Collection Request: New. Need and Use of Information Collection: The purpose of this information collection is to update occupational and environmental exposure information as well as medical history information for subjects enrolled in the in the Agriculture Health Study. The primary objectives of the study are to determine the health effects resulting from occupational and environmental exposures in the agricultural environmental. The findings will provide valuable information concerning the potential link between agricultural exposures and cancer and other chronic diseases among agricultural Health Study cohort members, and this information may be generalized to the entire agricultural community. Frequency of Response: Single time reporting. Affected Public: Individuals or households; farms; Type of Respondents: Licensed pesticide applicators and their spouses. The annual reporting burden is as follows: Estimated Number of Respondents: 74,714; Estimated Number of Responses per Respondent: 1; Average Burden Hours Per Response: 0.6179; and Estimated Total Annual Burden Hours Requested: 46,166. The annualized cost to respondents is estimated at: $461,660.00. There are no Capital Costs to report. There are no Operating or Maintenance Costs to report.
National Institutes of Health/National Institute of Environmental Health Sciences; Proposed Collection; Comment Request; Active Living by Design Program Evaluation
Document Number: 05-2772
Type: Notice
Date: 2005-02-14
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institute of Environmental Health Sciences (NIEHS), the National Institute of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Proposed Collection: Title: Active Living by Design Program Evaluation. Type of Information Collection Request: New. Need and Use of Information Collection: The purpose of this study is to provide NIEHS with an overall evaluation of the Active Living by Design (ALbD) program to determine the extent to which program strategies to increase physical activity influence change, as measured by increased physical activity and reduction of Body Mass Index (BMI), in residents of participating communities. The two objectives of this study are to determine: The degree to which the changes in the built environment, communication strategies and policy as a result of ALbD's program has impacted physical activity and BMI in residents within the twenty-five (25) participating communities relative to a set of ten (10) control communities; and The degree to which the ALbD program's communication strategies has positively impacted residents' knowledge and perceptions of features and conditions that impede and facilitate physical activity within their (participating) communities. Two types of data collection will occur throughout the study. A telephone and Internet survey, which relies on self-reports, will be conducted on a large sample of the population. A smaller population sample will be used during clinical surveys, which will collect physical activity data using measures of physical activity such as, accelerometers; measures of BMI and include a face-to-face interview on respondents' perceptions of their neighborhood. The findings of this study will provide valuable information concerning: (1) The direct impact ALbD strategies have on increasing physical activity and bringing about positive changes in health associated with exercise, such as weight loss: (2) possible reduction of health risks and diseases related to physical inactivity through implementation of ALbD strategies. Frequency of Response: Three times over a period of five (5) years; specifically during study years One (1), Three (3), and Five (5). Affected Public: Individuals or households. Type of Respondents: Respondents to telephone and internet surveys, includes adults, children ages 12 through 17 years and parents responding on behalf of children ages 6 through 11; Respondents to clinical surveys, includes adults and children ages 6-17. The clinical procedures require respondents under 18 years of age to be accompanied by their parent/guardian, therefore the burden has been doubled for these respondents. The annual reporting burden is represented in the following table:
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.